Argyle Capital Management Inc. Abbott Laboratories Transaction History

Argyle Capital Management Inc.

$248 Million
Q3 2024

A detailed history of Argyle Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Argyle Capital Management Inc. holds 3,850 shares of ABT stock, worth $451,451. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,850

Previous 3,715 3.63%

Holding current value

$451,451

Previous $386,000 13.47%

% of portfolio

0.18%

Previous 0.16%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$100.07 - $118.13 $13,509 - $15,947	135 Added 3.63%	3,850 $438,000
Q2 2024 Jul 29, 2024	SELL	$100.73 - $112.44 $292,117 - $326,076	-2,900 Reduced 43.84%	3,715 $386,000
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $284,098 - $347,760	-3,150 Reduced 32.26%	6,615 $728,000
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $100,780 - $112,290	-1,000 Reduced 9.29%	9,765 $1.06 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 1.82%	10,765 $1.29 Million
Q4 2020 Jan 28, 2021	SELL	$105.0 - $114.42 $131,250 - $143,025	-1,250 Reduced 10.23%	10,965 $1.2 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $112,992 - $137,220	-1,233 Reduced 9.17%	12,215 $1.33 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $30,627 - $39,200	-400 Reduced 2.89%	13,448 $1.23 Million
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $112,540 - $127,240	-2,000 Reduced 12.62%	13,848 $830,000
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $761,654 - $850,086	15,848	15,848 $846,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.

Account

Argyle Capital Management Inc. Abbott Laboratories Transaction History